Literature DB >> 9681519

Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system.

M Tamura1, H Kimura, T Koji, T Tominaga, K Ashizawa, T Kiriyama, N Yokoyama, T Yoshimura, K Eguchi, P K Nakane, S Nagataki.   

Abstract

Apoptosis, a physiological process of cell death, may modulate the mass of the thyroid gland. We investigated the role of apoptosis and the possible involvement of Fas/Fas ligand (FasL) system in apoptosis during goiter formation and involution in a rat model of goiter. Rats were fed a low iodine diet and a goitrogen, 6-propyl-2-thiouracil, to induce goiter. Rats with goiter were then fed a high iodine diet to study the phase of involution. We examined the presence of apoptosis by electron microscopy (EM) and terminal deoxy-UTP nick end labeling (TUNEL). We also investigated the association between Fas and FasL expression and thyrocyte apoptosis using immunohistochemistry and Western blotting. To evaluate the proliferation of thyrocytes, proliferating cell nuclear antigen was examined immunohistochemically. The number of apoptotic cells increased during goiter formation and the early stage of involution, which were also associated with increased number of Fas-positive thyrocytes, and some of these cells contained TUNEL-positive nuclei. However, the expression of FasL was almost constant throughout the experiment. Proliferating cell nuclear antigen/TUNEL ratio markedly increased during goiter formation but decreased particularly during the late stage of goiter involution. Our results indicate that apoptosis of thyrocytes is a main factor of cell loss during goiter formation and involution and suggest that the Fas/FasL system is involved in the induction of apoptosis of these cells. Moreover, the delicate balance between apoptosis and cell proliferation may play an important role in the control of thyroid gland mass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681519     DOI: 10.1210/endo.139.8.6140

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  The role of apoptosis in autoimmune thyroid disorders and thyroid cancer.

Authors:  J D Lin
Journal:  BMJ       Date:  2001-06-23

2.  Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.

Authors:  N Sera; A Kawakami; T Nakashima; H Nakamura; M Imaizumi; T Koji; Y Abe; T Usa; T Tominaga; E Ejima; K Ashizawa; N Yokoyama; N Ishikawa; K Ito; K Eguchi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Partial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppression.

Authors:  T Sawada; T Koji; Y Hishikawa; K Kishimoto; T Nagayasu; T Takahashi; T Oka; H Ayabe
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

4.  Inhibitory effect of Kangjia Pill on thyrocyte proliferation in rat goiter model.

Authors:  Yong Han; Jing Zhou; Shu-jing Yu; Bin Cui; Hai-qing Zhang; Ling Gao; Jia-jun Zhao
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

5.  AATF and SMARCA2 are associated with thyroid volume in Hashimoto's thyroiditis patients.

Authors:  Luka Brčić; Ana Barić; Benjamin Benzon; Marko Brekalo; Sanda Gračan; Dean Kaličanin; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ivana Novak; Valdi Pešutić Pisac; Ante Punda; Vesna Boraska Perica
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

6.  Single neonatal irradiation induces long-term gene expression changes in the thyroid gland, which may be involved in the tumorigenesis.

Authors:  Nariaki Fujimoto; Mutsumi Matsuu-Matsuyama; Masahiro Nakashima
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

7.  Histological and ultrastructural alterations of rat thyroid gland after short-term treatment with high doses of thyroid hormones.

Authors:  Njia M Ali Rajab; Mirela Ukropina; Maja Cakic-Milosevic
Journal:  Saudi J Biol Sci       Date:  2015-05-13       Impact factor: 4.219

8.  Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases.

Authors:  G Bona; S Defranco; A Chiocchetti; M Indelicato; A Biava; D Difranco; I Dianzani; U Ramenghi; A Corrias; G Weber; V De Sanctis; L Iughetti; G Radetti; U Dianzani
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.